Early stage venture capitalist.
Investor at LEAPS, the impact investment arm of Bayer.
I am responsible for developing investment cases and deal execution and also involved in the sourcing, screening, and mentoring of companies with game-changing science. Currently serving as board member for Egenesis, ($PYXZ) Pyxis Oncology, Immunitas Therapeutics, Khloris Biosciences, AffiniT, Mozart Tx, GRO, Azitra, Kojin therapeutics, Vesigen, Metagenomi
Ph.D. in Medicine at the Imperial College of London and a Master Degree in molecular biology from Cambridge University, Permanent learner
Invited by: Sultan Almaadeed
if the data has not been changed, no new rows will appear.
Day | Followers | Gain | % Gain |
---|---|---|---|
September 07, 2023 | 307 | 0 | 0.0% |
August 28, 2022 | 307 | +1 | +0.4% |
June 15, 2022 | 306 | +3 | +1.0% |
May 09, 2022 | 303 | +11 | +3.8% |
March 31, 2022 | 292 | +4 | +1.4% |
February 02, 2022 | 288 | +15 | +5.5% |
December 26, 2021 | 273 | +1 | +0.4% |
November 18, 2021 | 272 | +14 | +5.5% |
October 10, 2021 | 258 | +5 | +2.0% |
September 01, 2021 | 253 | +50 | +24.7% |